135 related articles for article (PubMed ID: 2393295)
1. Multiple-dose pharmacokinetics and safety of oral amifloxacin in healthy volunteers.
Cook JA; Silverman MH; Schelling DJ; Nix DE; Schentag JJ; Brown RR; Stroshane RM
Antimicrob Agents Chemother; 1990 Jun; 34(6):974-9. PubMed ID: 2393295
[TBL] [Abstract][Full Text] [Related]
2. Preliminary study of the pharmacokinetics of oral amifloxacin in elderly subjects.
Stroshane RM; Silverman MH; Sauerschell R; Brown RR; Boddy AW; Cook JA
Antimicrob Agents Chemother; 1990 May; 34(5):751-4. PubMed ID: 2360815
[TBL] [Abstract][Full Text] [Related]
3. Metabolism and disposition of amifloxacin in laboratory animals.
Johnson JA; Benziger DP
Antimicrob Agents Chemother; 1985 May; 27(5):774-81. PubMed ID: 4015071
[TBL] [Abstract][Full Text] [Related]
4. Multiple-dose pharmacokinetics and tolerability of gemifloxacin administered orally to healthy volunteers.
Allen A; Bygate E; Vousden M; Oliver S; Johnson M; Ward C; Cheon A; Choo YS; Kim I
Antimicrob Agents Chemother; 2001 Feb; 45(2):540-5. PubMed ID: 11158752
[TBL] [Abstract][Full Text] [Related]
5. Randomized, controlled trial of a 10-day course of amifloxacin versus trimethoprim-sulfamethoxazole in the treatment of acute, uncomplicated urinary tract infection. Amifloxacin Multi-Center Trial Group.
Boyko EJ; Iravani A; Silverman MH; Schelling DJ; Wright RA
Antimicrob Agents Chemother; 1990 Apr; 34(4):665-7. PubMed ID: 2188590
[TBL] [Abstract][Full Text] [Related]
6. Analysis of amifloxacin in plasma and urine by high-pressure liquid chromatography and intravenous pharmacokinetics in rhesus monkeys.
McCoy LF; Crawmer BP; Benziger DP
Antimicrob Agents Chemother; 1985 May; 27(5):769-73. PubMed ID: 4015070
[TBL] [Abstract][Full Text] [Related]
7. Double-blind evaluation of the safety and pharmacokinetics of multiple oral once-daily 750-milligram and 1-gram doses of levofloxacin in healthy volunteers.
Chien SC; Wong FA; Fowler CL; Callery-D'Amico SV; Williams RR; Nayak R; Chow AT
Antimicrob Agents Chemother; 1998 Apr; 42(4):885-8. PubMed ID: 9559801
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics and tolerance of lomefloxacin after sequentially increasing oral doses.
Morrison PJ; Mant TG; Norman GT; Robinson J; Kunka RL
Antimicrob Agents Chemother; 1988 Oct; 32(10):1503-7. PubMed ID: 3214495
[TBL] [Abstract][Full Text] [Related]
9. Multiple-dose pharmacokinetics and safety of trovafloxacin in healthy volunteers.
Teng R; Liston TE; Harris SC
J Antimicrob Chemother; 1996 May; 37(5):955-63. PubMed ID: 8737145
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics and tolerance of DU-6859a, a new fluoroquinolone, after single and multiple oral doses in healthy volunteers.
Nakashima M; Uematsu T; Kosuge K; Umemura K; Hakusui H; Tanaka M
Antimicrob Agents Chemother; 1995 Jan; 39(1):170-4. PubMed ID: 7695301
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of rufloxacin in healthy volunteers after repeated oral doses.
Mattina R; Bonfiglio G; Cocuzza CE; Gulisano G; Cesana M; Imbimbo BP
Chemotherapy; 1991; 37(6):389-97. PubMed ID: 1662127
[TBL] [Abstract][Full Text] [Related]
12. Multiple-dose pharmacokinetics and safety of ciprofloxacin in normal volunteers.
Gonzalez MA; Uribe F; Moisen SD; Fuster AP; Selen A; Welling PG; Painter B
Antimicrob Agents Chemother; 1984 Nov; 26(5):741-4. PubMed ID: 6517556
[TBL] [Abstract][Full Text] [Related]
13. Safety, tolerability and pharmacokinetics of the new long-acting quinolone DW-116 after single and multiple dosing in healthy subjects.
Meyerhoff C; Dilger C; Yoon SJ; Chung YH; Lee DK; Lee CW; Ryu JM; Choi MS; Pabst G; Reh C
J Antimicrob Chemother; 1998 Sep; 42(3):349-61. PubMed ID: 9786475
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of sarafloxacin in pigs and broilers following intravenous, intramuscular, and oral single-dose applications.
Ding HZ; Zeng ZL; Fung KF; Chen ZL; Qiao GL
J Vet Pharmacol Ther; 2001 Oct; 24(5):303-8. PubMed ID: 11696079
[TBL] [Abstract][Full Text] [Related]
15. Reversed-phase ion-pair high-performance liquid chromatographic determination of fluoroquinolones in human plasma.
Nangia A; Lam F; Hung CT
J Pharm Sci; 1990 Nov; 79(11):988-91. PubMed ID: 2292775
[TBL] [Abstract][Full Text] [Related]
16. Multiple-dose pharmacokinetics of lomefloxacin: rationale for once-a-day dosing.
Mant TG
Am J Med; 1992 Apr; 92(4A):26S-32S. PubMed ID: 1316066
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics and tolerability of gemifloxacin (SB-265805) after administration of single oral doses to healthy volunteers.
Allen A; Bygate E; Oliver S; Johnson M; Ward C; Cheon AJ; Choo YS; Kim IC
Antimicrob Agents Chemother; 2000 Jun; 44(6):1604-8. PubMed ID: 10817716
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetic disposition of sequential intravenous/oral ciprofloxacin in pediatric cystic fibrosis patients with acute pulmonary exacerbation.
Rubio TT; Miles MV; Lettieri JT; Kuhn RJ; Echols RM; Church DA
Pediatr Infect Dis J; 1997 Jan; 16(1):112-7; discussion 123-6. PubMed ID: 9002120
[TBL] [Abstract][Full Text] [Related]
19. Multiple-dose pharmacokinetics and safety of rufloxacin in normal volunteers.
Kisicki JC; Griess RS; Ott CL; Cohen GM; McCormack RJ; Troetel WM; Imbimbo BP
Antimicrob Agents Chemother; 1992 Jun; 36(6):1296-301. PubMed ID: 1329618
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of dexloxiglumide after administration of single and repeat oral escalating doses in healthy young males.
Persiani S; D'Amato M; Makovec F; Tavares IA; Bishai PM; Rovati LC
Int J Clin Pharmacol Ther; 2002 May; 40(5):198-206. PubMed ID: 12051571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
